By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Stocks Bounce Back, Close Sharply Higher Amid Omicron Concerns
Michael Robinson, Chief Technology Strategist at Money Map Press, joins Cheddar News' Closing Bell, where he explains why small and mid-cap stocks heating up during Tuesday's session is a very good sign for a stock market that ended the day's session sharply higher.
Could 2022 Be the Year Average Consumers Are Exposed to Crypto Transactions?
As the popularity of Bitcoin and other digital tokens grew this year, more financial institutions and payment apps added ways for customers to trade or make payments using cryptocurrency. Meanwhile, companies like theater chain AMC started accepting major cryptocurrencies for tickets and concessions, and retailers are rumored to be entering the space soon. What does this mean for cryptocurrency's wider adoption — and will 2022 be the year that the average consumer is exposed to digital coin payments on a regular basis? João Almeida, Co-Founder and CTO of OpenNode joins Cheddar News' Crypto Craze: The Year of the Token to discuss.
Bitcoin Set Up for Success in 2022, Altcoins Could Gain in Popularity
Bitcoin had a successful 2021: reaching a new high of nearly $70,000, a $1 trillion market cap, and becoming legal tender in El Salvador. Investors also got the chance to invest in three Bitcoin futures-backed ETFs once they were approved. These developments set up the world's best-known digital coin for more success in 2022, but could altcoins like Ethereum, Litecoin, and others move into the top spot or impact Bitcoin's value? Matt Hougan, CIO of Bitwise Asset Management, joins Cheddar's Crypto Craze: The Year of the Token to discuss his 2022 outlook for Bitcoin, whether we could see an ETF backed by a physical coin, and more.
Crypto Craze: Historic 2021 Campaign Paves Way for Continued Mainstream Adoption
Coming off a 2021 campaign where the prices of Bitcoin, Ether, and other cryptocurrencies reached unpreceded levels, Bitwise Asset Management CIO Matt Hougan and OpenNode Co-Founder & CTO João Almeida join Cheddar News' Crypto Craze: The Year of the Token to discuss the ways the crypto market can soar even higher in 2022.
Metaverse an Opportunity for Brands to 'Stay Refreshed' in Evolving Landscape
Howard Yu, LEGO professor of management and innovation at IMD Business School and author of "Leap: How to Thrive in a World Where Everything Can Be Copied," joined Cheddar to discuss the mania surrounding the concept of the metaverse. He particularly noted how companies in the retailing sector like Nike are leveraging it. "I think metaverse really opens up a window for brands to think about how can they, ongoing-wise, engage with the consumer, engage with the target audience, so their brand continues to stay refreshed in the changing environment," Yu said.
Integrity Marketing Group Gifts $125 Million to its Employees
Integrity Marketing Group, nation's largest independent distributor of life and health insurance products, is showing its employees it cares. The company surprised its 5,500 employees with $125 million in cash payouts to those participating in the company's Employee Ownership Plan. Bryan Adams, CEO of at Integrity Marketing Group, and Steve Young, NFL Hall of Famer and chairman of the board at Integrity Marketing Group, join Cheddar News to talk about the announcement.
Pro Sports Scramble Over Covid-19 Omicron Variant
Anthony Tall, sports agent and president of Miracle Sports Agency, joins Cheddar News to talk about the challenges professional sports leagues are facing amid a surge in coronavirus cases across the U.S.
Load More